chrisvoncsefalvay/vaers-outcomes huggingface dataset:
redness came out it's like a map.; arm redness, a bit sore and muscle pain..; arm redness, a bit sore and muscle pain..; arm redness, a bit sore and muscle pain..; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (arm redness, a bit sore and muscle pain..), PAIN (arm redness, a bit sore and muscle pain..), MYALGIA (arm redness, a bit sore and muscle pain..) and ERYTHEMA (redness came out it's like a map.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history information was reported.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced ERYTHEMA (arm redness, a bit sore and muscle pain..), PAIN (arm redness, a bit sore and muscle pain..) and MYALGIA (arm redness, a bit sore and muscle pain..). On an unknown date, the patient experienced ERYTHEMA (redness came out it's like a map.). At the time of the report, ERYTHEMA (arm redness, a bit sore and muscle pain.), PAIN (arm redness, a bit sore and muscle pain.) and MYALGIA (arm redness, a bit sore and muscle pain.) had resolved and ERYTHEMA (redness came out it's like a map.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Feb-2021 and was forwarded to Moderna on 08-Feb-2021.    This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (arm redness, a bit sore and muscle pain..), PAIN (arm redness, a bit sore and muscle pain..), MYALGIA (arm redness, a bit sore and muscle pain..) and ERYTHEMA (redness came out it's like a map.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history information was reported.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced ERYTHEMA (arm redness, a bit sore and muscle pain..), PAIN (arm redness, a bit sore and muscle pain..) and MYALGIA (arm redness, a bit sore and muscle pain..). On an unknown date, the patient experienced ERYTHEMA (redness came out it's like a map.). At the time of the report, ERYTHEMA (arm redness, a bit sore and muscle pain.), PAIN (arm redness, a bit sore and muscle pain.) and MYALGIA (arm redness, a bit sore and muscle pain.) had resolved and ERYTHEMA (redness came out it's like a map.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported.
faint 2days ago; lt arm swollen & red 101 went hlth stop;
Patient notes he has had 2-3 weeks of chest pressure and doe. He came in today due to pain radiating down his left arm. He denies sob at rest. He denies f/c/ns. He had an echo on 9/8, limited looking at the aortic valve. He has also had a heart cath in April with no significant stenosis.  In the ER today, cxr with some mild edema, EKG stable from prior, covid swab ended up positive. He had covid in Jan this year, but also was vaccinated in May. April swab was negative. The patient notes he has had a dry cough for a couple of weeks.  Chest pain with DOE-   His troponin is elevated and trending upward, but no acute EKG changes, and a heart cath in April without significant obstructive CAD.  He just had an echo 2 weeks ago and repeat done here shows no effusion       Given heart cath and stress test findings and new anemia, it is most likely he has type 2 nstemi/DOE brought on by the anemia or a mild case of myocarditis from COVID       Troponin up this am, but no pain and asymptomatic, repeat trended back down   ----Covid 19 positive- incidental finding, admitted to covid unit per protocol, but sounds like he has had a dry cough for 2 weeks (attributed to bailing hay). No specific treatment needed as he is not on oxygen (requested it on but not requiring) . He had covid in Jan and received monoclonal abs at that time, and also his vaccine in May. This is either residual COVID nasal swab positivity OR more likely a more recent exposure of COVID to his nasopharynx and his vaccine worked, and not ill from it.   ----Farmer's lung- continue budesonide/formoterol in patient.    ----Systolic CHF, chronic with maybe mild acute exacerbation- continue bumex and beta blocker, held aldactone, with BPs soft  Discharged on 09/25/2021.
Started feeling light headed. At initial question set he marked no allergies and no health conditions. After the vaccine he admitted to having hypertension and hasn't taken his meds in 2 days. Checked his BP and gave him water (see below). Monitored him for 30min and he still felt dizziness. Staff recommended he take an ambulance to hospital as a precaution so he agreed to go.
This spontaneous report was received from a healthcare worker (also reported as nurse) refers to a patient of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On 07-JAN-2015, the patient was vaccinated with a dose of PEDVAXHIB, (strength, dose, route and anatomical location were not reported), (lot # J016186, expiration date: 24-OCT-2016), which was incorrect stored since 02-DEC-2014. No adverse effects were reported and no product quality complaint (PQC) was filled. This is one of several reports received from the same reporter. Additional information has been requested.
Symptoms started a little less than 24 hours later. Some stiffness in left arm started in the morning after the shot. Other symptoms were mild fatigue and persistent headache. I got the shot Friday evening, all side effects were gone by early Sunday. I took ibuprofen and Tylenol as advised by pharmacist.
has had tinnitus for the past 25 years/ the tinnitus completely disappeared; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 24Mar2021 (Lot number: EN6204) at the age of 76 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "tinnitus" (unspecified if ongoing), notes: in his early 50s (for the past 25 years), due to gunshot noise. There were no concomitant medications. Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Lot number: EN6205), administration date: 03Mar2021, when the patient was 76 years old, for COVID-19 immunisation. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset 25Mar2021 20:00, outcome "unknown", described as "has had tinnitus for the past 25 years/ the tinnitus completely disappeared".  No follow-up attempts are possible. No further information is expected.
I got shingles on my back, my face and as of today, April 6, 2021, it appears I may be getting shingles at the vaccination site.  It feels like shingles is coming -- its red and itchy and hurts.  I will take the antiviral to suppress it.
felt very different, very tired, lethargic, after last shot to today.  took me 4 yrs to get pregnant.  joint soreness to today, heart palpitations recently w/no answer for.      not sure of exact dates of vaccination - see doctor's file.
Swelling and redness from site of injection to elbow on L arm; treatment: applied cool compress.
This spontaneous report was received from a physician via company representative and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 03-SEP-2014, the patient was vaccinated with a  0.5 ml dose of PNEUMOVAX 23 "10 Single DS 0.5 ml LVIs 10SDV", lot # K004148, expiration date 10-MAY-2015 (route was not reported). This vaccine was improperly stored exposed to temperature excursion for a sum of 72 hours at a lowest temperature recorded of 34 degrees F (1.111111111 degrees C). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator(R)". No adverse effects were reported. There was no product quality complained involved. This is one of several reports received from the same reporter. Additional information has been requested.
mom reports pt devel sore throat next day, t100.6, did not feel well but has hx of sore throat 1DEC92; better 2DEC92;
Vial was at room temperature for 25 hours; No Adverse event; bivalent vaccine given to patient from a vial punctured more than 12 hours ago; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago), PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours) and NO ADVERSE EVENT (No Adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 059F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago), PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent vaccine given to patient from a vial punctured more than 12 hours ago) and PRODUCT STORAGE ERROR (Vial was at room temperature for 25 hours).    Patients were all over the age of 65. No concomitant medication were reported.   Patient received Bivalent vaccine. Vial size was 5.5ml The vial was initially stored in the refrigerator on 12-OCT-2022. The vial was first punctured on 19-OCT-2022 10:00AM. The vaccine was administered on 20-OCT-2022 at 10:13, 10:15 and 11:00 respectively for 3 patients. The vial was stored at room temperature post puncture .  The vial did not undergo any temperature excursions. The vial was exposed to room temperature range for just over 25 hours.  No treatment information was provided by the reporter. This case was for first patient out of 3 patients described by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-661792, US-MODERNATX, INC.-MOD-2022-661793 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-661793:Patient 3 US-MODERNATX, INC.-MOD-2022-661792:patient 2
Day 1 - fever of 102, body aches, headache, could barely move Rt. arm, tight chest, little appetite.  Day 2 - temp down to 100, body aches more mild, still a headache, pain near groin lymph nodes, arm more mobile but now with a red hot and painful lesion
pt recv vax 13JUN94 & w/in 18 hr of the vax pt devel hives all over body; No further details were provided;
Client complain of severe pain under right arm-axilla unable to move arm above 45 degree angle.  Pain sometimes radiate down arm to hand.  Upper inner arm is warm to touch.  Referred to Doctor, he diagnose lymph node infection patient put on Bextra 20mg daily.
Patient reported at 1:39 pm that she was feeling " hot and like blood pressure was through the roof". Patient flushed in neck and chest area, redness- no hives or rash. BP 138/80 HR 106 oxygen 96. Reported no trouble swallowing, swelling, dizziness or breathing. NP had patient stay in exam room to continue to monitor. 1:59 pm BP 130/82 HR 86 oxygen 96. patient reports starting to feeling better at this time, less redness on neck and chest. 2:11 pm patient reports she is " cooled down, feeling better" 130/80 BP, HR 87 and oxygen 99 (deep breaths without mask at this time)). Patient in no apparent distress, talking calmly, able to drink water.
Awoke with numb left thigh.  Progessed to overall body weakness, pain and fatigue.  Diagnosed with chronic polyradiculoneuropathy in Oct 2011.  Symptoms still persist.  Being treated with Lyrica, Tramadol, Percocet for pain.  Receive weekly infusions of Hizentra.
had the shot but got shingles/ Suspected Vaccination Failure; got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the shot but got shingles/ Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: got shingles). The outcome of the vaccination failure and shingles were not reported.   It was not reported if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was not reported if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 02-MAR-2023 This case was reported by a patient via interactive digital media. The patient had the shot a long time ago but got shingles. The patient reported that, it depends on the person apparently, some get the shot and do okay but there are those that have bad side effects. The patient was told extreme stress could cause shingles. The patient was very upset and stressed out when he/she got shingles. The patient stated that it was hard to know what to do. The follow-up could not be possible as no contact details were available. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting
Rash, erythema, tenderness and petchiae at both sites of vaccinations (Both thighs). Patient was seen in office after 2 days. Pt seen in office with erythema, tenderness bot none injection; was improving after 2 days.
49 y/o female without significant PMH other than anaphylaxis  from a dental procedure, who presents to the emergency room with multiple complaints after receiving her second SARS-CoV-2 Pfizer vaccination today at about 3-3:30 PM, lot number not current available. The patient's significant other/boyfriend was driving when he noticed the patient suddenly started to complain of  shortness of breath with chest pain and a maculopapular rash which later was followed by expressive aphasia and left hemiparalysis. She received Pepcid, solumedrol and Benadryl for the rash in the ER with improvement. Code neuro was called and TPA was given. Post TPA she was alert and oriented and she could currently write with her right hand and think of the words she has to say.  She had associated blurry vision which has resolved after TPA was administered. She also was not able to move her left lower extremity nor her left upper extremity which is also improving to some extent after TPA administration. So far CT/CTA head and CTA neck are negative and she has been admitted for likely acute cerebral vascular accident.
eight minutes after the vaccine I was waiting for my after dose evaluation, I started feeling numbness on left side of my face, I was taken to the ER, it went down to the left side of my neck and my left arm, after an hour I couldn't move the entire left side of my body, they did an MRI and admitted me to overnight observation. next morning I was discharged (friday), physical therapy and occupational therapy came in to help me adjust because I was still numb I was given a walker and a knee brace, I went home. Saturday I started getting feeling in my face and neck. Sunday I was still gaining more sensation, Monday I had full sensation every where except my leg, Tuesday I had complete feeling on my entire left side. 7 days after my shot on wednesday I started having cold chills body aches and fever nausea and diarrhea,  by thursday I couldn't eat anything in me I would have diarrhea. I went to the ER on Saturday, they ran tests CT scan and found entera colitis and was admitted again, they started me on iv antibiotics and fluids , no solid food, they tested my stool and everything came back normal.  I was discharged because the diarrhea had stopped, I was having regular bowl movements. Dr said it may or may not have been a cause from the vaccine, they weren't sure.
DEVELOPED A RASH SURROUNDING INJECTION SITE. APPROXIMATELY 3" IN DIAMETER. RASH HAS MULTIPLE LESIONS VESICULAR IN NATURE. MEMBER STATES RASH ITCHES. NO FEVER OR OTHER C/O AT THIS TIME BUT MEMBER IS RECOVERING FROM ANOTHER RASH ON HIS LEG THAT DEVELOPED PRIOR TO HAVING ANY ANTHRAX VACCINATIONS.
The morning after my covid-19 shot I have a sore throat; This is a spontaneous report from a contactable consumer (patient himself). A 73 (unit: unknown) old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in left arm on 03Feb2021 as 1st dose, single for COVID-19 immunization. Vaccine facility type was reported as Hospital. Patient did not receive any other vaccine within four weeks. Patient did not had COVID-19 prior to vaccination. Patient was not tested for COVID-19 post vaccination. Patient medical history and concomitant medications were not reported. Patient had no known allergies. On 04Feb2021 at 00:00, the morning after patient's covid-19 shot he had a sore throat. Patient did not receive any treatment for the adverse events. The outcome of the event was resolving.   Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
At time of vaccination patient felt fine. Morning after: patient stated he had a fever. At presentation  to pharmacy(11:00am) , temperature checked any no fever was present. Patient stated he felt tired and couldn't catch his breath. Patient was encouraged to go home and rest as most of the described symptoms were to be expected. He did not. He reported back to pharmacy after 5:00pm and stated at around 2:00pm he felt dizzy and then went unconscious for a brief time (he did not know exact time frame but stated not long. Again temp was checked and was normal. He stated that his breathing was improving, but he was taking rest of day off.
Small stroke. TIA.  Left side of body went partially numb.  Difficulty opening mouth. All symptoms subsided in 48 hours.
soreness at the site, more soreness than after her first shot.; This is a spontaneous report from a contactable consumer reporting for a female patient (nephew's fiance). A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on 17Jan2021 as a single dose in the left arm for COVID-19 vaccination. Relevant medical history and concomitant medication were not provided. The patient previously received the first dose of BNT162B2 on 27Dec2020 and experienced soreness at the site, fatigue, and numbness in the left pinky finger (same arm as vaccination). On an unspecified date in Jan2021, the patient experienced soreness at the site, more soreness than after her first shot. The outcome of the event soreness at the site was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Extreme exhaustion; chills; minor rash; sore at injection site; dizziness; mild bump at injection site; This is a spontaneous report from a contactable consumer. A 19-Year-old female patient received Pfizer Covid 19 (BNT162B2) (Batch/Lot number: En6201, Expiration date: Unknown, Solution for injection), on 17Mar2021 around 12:00 PM on left Arm as Dose 1 single for covid 19 immunization (age at vaccination:19-Year-old). Medical history was reported as unknown. Concomitant medications included Pantoprazole, Junelfe within 2 weeks. Other medications in two weeks included Multivitamin and Probiotic medications. The patient had not received any other vaccine in four weeks. The patient had not affected with covid19 before or after vaccination. On 17Mar2021 around 01:30 PM patient experienced Extreme exhaustion, chills, minor rash, sore at injection site, dizziness and mild bump at injection site. It was reported that patient was not pregnant at the time of vaccination. The patient had not involved in any prolonged hospitalisation. No therapeutic treatments were received. On an unspecified date the outcome of the events was reported as recovering/resolving.   Follow-up attempts completed. No further information expected.
a school exposure and her pod was tested/she tested positive; a school exposure and her pod was tested/she tested positive; stomach ache; This is a spontaneous report received from a contactable consumer or other non hcp.  A 11 year-old female patient received BNT162B2 (COMIRNATY) (Batch/Lot number: unknown) at the age of 11 years as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 13Jan2022, outcome "unknown" and all described as "a school exposure and her pod was tested/she tested positive"; ABDOMINAL PAIN UPPER (non-serious) with onset 13Jan2022, outcome "unknown", described as "stomach ache". It was reported that patient had a school exposure and her pod was tested. She tested positive on 13Jan2022 and reported sore throat and stomach ache. On 14Jan2022 developed fever to 103, lethargic. The patient underwent the following laboratory tests and procedures: body temperature: (14Jan2022) 103, notes: fever to 103; COVID-19 test: (13Jan2022) positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
pt recvd vax; itching after 2 days w/ hives; 28dec93 no response to f/u request;
NEUROPATHY 12/22/2022 BRIGHT RED BLOOD PER RECTUM ACUTE NON ST ELEVATION MI 10/8/2022 BRIGHT RED BLOOD PER RECTUM ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 10/9/2022 BRIGHT RED BLOOD PER RECTUM LEFT FACIAL MUSCLE WEAKNESS 10/8/2022 BRIGHT RED BLOOD PER RECTUM NEUROPATHY 12/22/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE NON ST ELEVATION MI 10/8/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 10/9/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY LEFT FACIAL MUSCLE WEAKNESS 10/8/2022 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY